Efficient Design of Affilin(R) Protein Binders for HER3
Diaz-Rovira, A. M.; Lotze, J.; Hoffmann, G.; Pallara, C.; Molina, A.; Coburger, I.; Gloser-Bräunig, M.; Meysing, M.; Zwarg, M.; Diaz, L.; Guallar, V.; Bosse-Doenecke, E.; Roda, S.
Show abstract
Engineered scaffold-based proteins that bind to concrete targets with high affinity offer significant advantages over traditional antibodies in theranostic applications. Their development often relies on display methods, where large libraries of variants are physically contacted with the desired target protein and pools of binding variants can be selected. Herein, we use a combined artificial intelligence/physics-based computational framework and phage display approach to obtain ubiquitin based Affilin(R) proteins targeting the HER3 extracellular domain, a relevant tumor target. We demonstrate that the developed in silico pipeline can generate de novo Affilin(R) proteins with high experimental success rate using a small training set of sequences (<1000 sequences). The classical phage display yielded primary candidates with low nanomolar affinities. These binders could be further optimized by phage display and computational maturation alike. These combined efforts resulted in four HER3 ligands with high affinity, cell binding, and serum stability that have theranostic potential.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Enhancement of antibody thermostability and affinity by computational design in the absence of antigen 94%
- Towards generalizable prediction of antibody thermostability using machine learning on sequence and structure features 93%
- Development of potent humanized TNFα inhibitory nanobodies for therapeutic applications in TNFα-mediated diseases 93%
Similar papers in this journal
- TMPRSS2 inhibitor discovery facilitated through an in silico and biochemical screening platform 93%
- Lysineless HiBiT and NanoLuc Tagging Systems as Alternative Tools Monitoring Targeted Protein Degradation 92%
- Evaluation of High-Affinity Monoclonal Antibodies and Antibody-Drug Conjugates by Homogenous Time-Resolved FRET 90%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.